ETBX-011

DB17464Investigational

ETBX-011 is a cancer vaccine used to treat patients with cancers that express carcinoembryonic antigen (CEA).

Mechanism: Pharmacologically active on Cell adhesion molecule CEACAM5
Curator reviewed
Code names: ETBX-011

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

17Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with ETBX-011, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.